Neumentum
Palo Alto, US · Founded 2017 · Delaware corporation · 1 known investors
Neumentum is a specialty pharmaceutical company developing non-opioid analgesic and neurology products for pain management. It has four novel non-opioid products in development aimed at treating pain while avoiding the abuse, misuse, and respiratory side effects associated with opioids.
Founders & leadership
RS
Richard Scott ShivelyNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$32.5M disclosed across 5 rounds · 2017–2021
▶$16.6MraisedApr 2023 · 33 investors · PharmaceuticalsRule 506(b)
▶$16.6MraisedApr 2023 · 33 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Taggart McGurrinExecutive Officer
- Joseph PergolizziDirector
- August MorettiDirector
- Andrew BlankDirector
- Offering amount
- $20M
- Amount sold
- $16.6M
- Sales commissions
- $300K
- Proceeds to insiders
- $777.3K
- Placement agents
- Brookline Capital Markets, a division of Arcadia Securities, LLC
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.7MraisedNov 2019 · 18 investors · PharmaceuticalsRule 506(b)
▶$2.7MraisedNov 2019 · 18 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Richard Scott ShivelyExecutive Officer
- Joseph PergolizziDirector
- August MorettiDirector
- Pedro GranadilloDirector
- Ilona SteigerwaldExecutive Officer
- Christine CvijicExecutive Officer, Director
- Offering amount
- $7M
- Amount sold
- $2.7M
- Sales commissions
- $420K
- Proceeds to insiders
- $660K
- Placement agents
- CIM Securities, LLC, Arcadia Securities, LLC
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$3MraisedSep 2019 · 36 investors · PharmaceuticalsRule 506(b)
▶$3MraisedSep 2019 · 36 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Pedro GranadilloDirector
- Christine Mikail CvijicExecutive Officer, Director
- Joseph PergolizziDirector
- Richard Scott ShivelyExecutive Officer, Director
- August MorettiDirector
- Ilona SteigerwaldExecutive Officer
- Offering amount
- $7M
- Amount sold
- $3M
- Sales commissions
- $420K
- Proceeds to insiders
- $930K
- Placement agents
- Arcadia Securities, LLC, CIM Securities, LLC
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$5MraisedMay 2018 · 38 investors · PharmaceuticalsRule 506(b)
▶$5MraisedMay 2018 · 38 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Joseph PergolizziDirector
- Richard Scott ShivelyExecutive Officer, Director
- Pedro GranadilloDirector
- Ilona SteigerwaldExecutive Officer
- Christine Mikail CvijicExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $5M
- Sales commissions
- $700K
- Proceeds to insiders
- $1M
- Placement agents
- CIM Securities, LLC
- First sale
- May 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$5.3MraisedOct 2017 · 53 investors · PharmaceuticalsRule 506(b)
▶$5.3MraisedOct 2017 · 53 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Richard Scott ShivelyExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $5.3M
- Sales commissions
- $420K
- Proceeds to insiders
- $900K
- Placement agents
- Brookline Capital Markets, a division of CIM Securities, LLC
- First sale
- Oct 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 6
by search overlapMirum Pharmaceuticals8 shared keywordsMirum Pharmaceuticals is a biopharmaceutical company that develops and delivers therapies for people living with rare diseases. It operates in the U.S. and Europe, engaging with healthcare professionals, patients, and payers within applicable regulatory frameworks.
Elementum6 shared keywordsElementum offers an AI-native workflow and business process automation platform that runs inside a company's own data cloud, positioned as a replacement for legacy enterprise SaaS. It targets large enterprises and is pre-integrated with AI/ML/LLM tools, using a "Zero Persistence" architecture so customer data does not persist in its systems.
Amentum5 shared keywordsAmentum delivers engineering, design, and project management services for advanced energy solutions, including nuclear, fusion, and hydrogen technologies. The company serves energy clients worldwide seeking to transition away from fossil fuels and develop next-generation power systems.
Crew324 shared keywordsCrew32 maintains a database of compensation and workplace culture information that companies can compare against industry benchmarks. Its data is segmented by factors such as gender, experience level, region and company size, and includes startup salary figures indexed to the amount of venture funding a company has raised.
Globaldata4 shared keywordsGlobalData provides an AI-powered intelligence platform that delivers research, market analysis, and predictive insights to enterprises across industries. The platform combines proprietary data, in-house subject matter experts, and AI tools to support critical business decisions.
Mobileum4 shared keywordsMobileum provides software for telecom operators to monetize network data, manage risk and fraud, optimize traffic (roaming/steering), secure networks and signaling, and assure IoT and eSIM services. Its AI and analytics platform serves communications service providers with revenue assurance, fraud detection, network security, and customer intelligence solutions.
Companies competing with Neumentum for the same Google search keywords, organic and paid, via search-intersection analysis.
Legal entities · 1
corporate structureNeumentumDelaware
In the news
Frequently asked questions
- What does Neumentum do?
- Neumentum is a specialty pharmaceutical company developing non-opioid analgesic and neurology products for pain management. It has four novel non-opioid products in development aimed at treating pain while avoiding the abuse, misuse, and respiratory side effects associated with opioids.
- Who are Neumentum's investors?
- Neumentum's investors include Evolution VC Partners.
- How much funding has Neumentum raised?
- Neumentum has disclosed $32.5M raised across 5 rounds.
- Where is Neumentum headquartered?
- Neumentum is headquartered in Palo Alto, US.